Table 4.
Linear mixed modeling estimates of wound closure for each treatment, relative to untreated controls (higher co-efficient corresponds with slower wound healing).
| Treatment | Fibroblasts | HNEC | Differential |
|---|---|---|---|
| Cell migration speed—linear mixed modeling | |||
| Doxycycline | 0.276 | 0.064 | −0.212 |
| Mitoquinone | 0.255 | 0.072 | −0.183 |
| Clarithromycin | 0.294 | 0.183 | −0.111 |
| Ciprofloxacin | 0.163 | 0.056 | −0.107 |
| Roxithromycin | 0.252 | 0.196 | −0.056 |
| Azithromycin | 0.132 | 0.09 | −0.042 |
| Linezolid | 0.11 | 0.091 | −0.019 |
| Clindamycin | 0.172 | 0.168 | −0.004 |
| Mupirocin | 0.095 | 0.094 | −0.001 |
| Erythromycin | 0.102 | 0.128 | 0.026 |
| Augmentin | 0.129 | 0.185 | 0.056 |
| Amoxicillin | 0.167 | 0.225 | 0.058 |
| Tedizolid | 0.076 | 0.205 | 0.129 |
Negative differential represents tendency for slowing fibroblasts relative to HNEC, positive differential represents tendency for slowing HNEC relative to fibroblasts.